Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Effects of ergotamine on isolated human vessels

Arch Int Pharmacodyn Ther. 1981 Aug;252(2):241-52.

Abstract

In isolated human mesenteric and crural veins, ergotamine induced long-lasting contractions. These contractions were resistant to repeated wash-out and were not affected by alpha-adrenoceptor blockade, but could be abolished by removal of extracellular calcium or by the presence of the calcium-blocker nifedipine. In contrast to its effect on human mesenteric and crural veins, ergotamine had no contractile effect, but a marked relaxant effect on mesenteric arteries mediated via blockade of alpha-receptors. The ergotamine-induced contraction was not affected by indomethacin (0.28--2.8 microM) nor was it influenced by serotonin (5-HT). In both mesenteric and crural veins, the ergotamine-induced contraction was diminished by the 5-HT blocking agent, methysergide. In veins, development of tachyphylaxis to 5-HT was demonstrated. It is concluded that ergotamine has a direct contractile effect on isolated human mesenteric and crural veins. These effects are dependent on unhindered influx of extracellular calcium and are at least partly mediated via 5-HT receptors. In mesenteric arteries, ergotamine acted as an alpha-adrenoceptor blocker, and had no contractant effect.

MeSH terms

  • Adult
  • Aged
  • Drug Interactions
  • Ergotamine / pharmacology*
  • Female
  • Humans
  • In Vitro Techniques
  • Indomethacin / pharmacology
  • Male
  • Methysergide / pharmacology
  • Middle Aged
  • Muscle Contraction / drug effects*
  • Muscle, Smooth, Vascular / drug effects*
  • Norepinephrine / pharmacology
  • Phentolamine / pharmacology
  • Potassium / pharmacology
  • Serotonin / pharmacology

Substances

  • Serotonin
  • Ergotamine
  • Potassium
  • Norepinephrine
  • Indomethacin
  • Methysergide
  • Phentolamine